Literature DB >> 8383654

Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria.

P C Appelbaum1.   

Abstract

Current data are summarized on the comparative susceptibility of Gram-positive and Gram-negative anaerobic bacteria to piperacillin/tazobactam and other anti-anaerobe agents. For beta-lactamase-positive organisms, tazobactam, in fixed concentration or fixed ratio, lowered the MIC of piperacillin at least four-fold to susceptible levels in almost all cases; beta-lactamase-negative strains were all susceptible to piperacillin alone. Susceptibility rates and MIC90 values for piperacillin/tazobactam were comparable to those of other anti-anaerobe agents, including other combinations of beta-lactam agents with beta-lactamase inhibitors, such as amoxycillin/clavulanate, ticarcillin/clavulanate, ampicillin/sulbactam and cefoperazone/sulbactam. Kinetic studies revealed IC50 and Ki values for tazobactam that were in most cases lower than those of clavulanate and sulbactam against beta-lactamase-positive Gram-negative anaerobic bacilli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383654     DOI: 10.1093/jac/31.suppl_a.29

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Assessment of biliary excretion of piperacillin-tazobactam in humans.

Authors:  J F Westphal; J M Brogard; F Caro-Sampara; M Adloff; J F Blicklé; H Monteil; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.

Authors:  J Wüst; U Hardegger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

Review 3.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.

Authors:  M D Reed; J Goldfarb; T S Yamashita; E Lemon; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.